National Institute for Health and Care Research, Southampton Biomedical Research Centre, University Hospital Southampton, Southampton, United Kingdom, United Kingdom
Disclosure information not submitted.
1A-05 - End-stage renal diseases associated with the use of SGLT2 inhibitors versus GLP-1 receptor agonists among individuals with metabolic dysfunction-associated steatotic liver disease: A nationwide cohort study
Sunday, August 24, 202511:30 AM - 11:45 AM ET
